Model Predictive Control of Type 1 Diabetes: An in Silico Trial
Предиктивное управление сахарным диабетом 1-го типа: исследование in silico
2007-11-01
SCID: 54.1/ra7779ua
Discuss with AI
artificial pancreascontinuous glucose monitoringin silico trialmodel predictive controltype 1 diabetes mellitus
Figures from the paper
Abstract (AI)
BACKGROUND: The development of artificial pancreas has received a new impulse from recent technological advancements in subcutaneous continuous glucose monitoring and subcutaneous insulin pump delivery systems. However, the availability of innovative sensors and actuators, although essential, does not guarantee optimal glycemic regulation. Closed-loop control of blood glucose levels still poses technological challenges to the automatic control expert, most notable of which are the inevitable time delays between glucose sensing and insulin actuation. METHODS: A new in silico model is exploited for both design and validation of a linear model predictive control (MPC) glucose control system. The starting point is a recently developed meal glucose-insulin model in health, which is modified to describe the metabolic dynamics of a person with type 1 diabetes mellitus. The population distribution of the model parameters originally obtained in healthy 204 patients is modified to describe diabetic patients. Individual models of virtual patients are extracted from this distribution. A discrete-time MPC is designed for all the virtual patients from a unique input-output-linearized approximation of the full model based on the average population values of the parameters. The in silico trial simulates 4 consecutive days, during which the patient receives breakfast, lunch, and dinner each day. RESULTS: Provided that the regulator undergoes some individual tuning, satisfactory results are obtained even if the control design relies solely on the average patient model. Only the weight on the glucose concentration error needs to be tuned in a quite straightforward and intuitive way. The ability of the MPC to take advantage of meal announcement information is demonstrated. Imperfect knowledge of the amount of ingested glucose causes only marginal deterioration of performance. In general, MPC results in better regulation than proportional integral derivative, limiting significantly the oscillation of glucose levels. CONCLUSIONS: The proposed in silico trial shows the potential of MPC for artificial pancreas design. The main features are a capability to consider meal announcement information, delay compensation, and simplicity of tuning and implementation.
Key Findings
1
A discrete-time linear model predictive controller was designed for virtual patients using a single input-output-linearized model based on average population parameters.
2
A new in silico type 1 diabetes model was developed by adapting a meal glucose-insulin model and modifying healthy-population parameter distributions for diabetic patients.
3
After straightforward individual tuning of the glucose-error weight, satisfactory glycemic regulation was achieved despite relying only on the average patient model.
4
MPC provided better glucose regulation than proportional-integral-derivative control and significantly limited ...
5
Meal announcements improved MPC control, while imperfect estimates of ingested glucose caused only marginal performance deterioration.
Research Object
in silico virtual patients with type 1 diabetes mellitus receiving insulin therapy and meals
Research Subject
model predictive control of blood glucose regulation, including the effects of meal announcements, parameter variability, and glucose-intake uncertainty
Publication Details
Publication Date
2007-11-01
Journal
Publisher
ISSN
Cited by
324
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai1
Cited by13
In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes2009
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: The Virginia Experience2009
A Closed-Loop Artificial Pancreas Using Model Predictive Control and a Sliding Meal Size Estimator2009
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier2009
Individualized model predictive control for the artificial pancreas: In silico evaluation of closed-loop glucose control2018
Artificial Pancreas: Model Predictive Control Design from Clinical Experience2013
Closed-loop insulin delivery for treatment of type 1 diabetes2011
In Silico Preclinical Trials: Methodology and Engineering Guide to Closed-Loop Control in Type 1 Diabetes Mellitus2009
An Insulin Infusion Advisory System Based on Autotuning Nonlinear Model-Predictive Control2011
Insulin Patch Pumps: Their Development and Future in Closed-Loop Systems2010
Reducing risk of closed loop control of blood glucose in artificial pancreas using fractional calculus2014
Intelligent Closed-Loop Insulin Delivery Systems for ICU Patients2013
Deep Reinforcement Learning Control of Type-1 Diabetes with Cross-Patient Generalization2024